| Characteristic . | Population (n = 1062) . |
|---|---|
| Age (years) | 59.2 ± 9.9 |
| Gender (female) | 222/1062 (21) |
| Current smoking | 389/1055 (37) |
| Diabetes | 177/1062 (17) |
| Hypertension | 584/1053 (55) |
| Body mass index (kg/m2) | 26.9 (3.9) |
| Total cholesterol (mmol/l) | 4.9 (1.0) |
| HDL cholesterol (mmol/l) | 1.3 (0.4) |
| LDL cholesterol (mmol/l) | 2.8 (0.9) |
| eGFR (MDRD, ml/min/1.73m2) | 77.4 (17.8) |
| C-reactive protein (mg/l) | 1.8 (67.2–88.7) |
| History of coronary artery disease | 617/1062 (58) |
| History of cerebrovascular disease | 290/1062 (27) |
| History of peripheral artery disease | 264/1062 (25) |
| History of abdominal aorta aneurysm | 109/1062 (10) |
| Statin use | 721/1046 (69) |
| Antihypertensive medication | 752/1062 (71) |
| Platelet aggregation inhibitors | 792/1051 (75) |
| Oral anticoagulants | 85/1062 (8) |
| Characteristic . | Population (n = 1062) . |
|---|---|
| Age (years) | 59.2 ± 9.9 |
| Gender (female) | 222/1062 (21) |
| Current smoking | 389/1055 (37) |
| Diabetes | 177/1062 (17) |
| Hypertension | 584/1053 (55) |
| Body mass index (kg/m2) | 26.9 (3.9) |
| Total cholesterol (mmol/l) | 4.9 (1.0) |
| HDL cholesterol (mmol/l) | 1.3 (0.4) |
| LDL cholesterol (mmol/l) | 2.8 (0.9) |
| eGFR (MDRD, ml/min/1.73m2) | 77.4 (17.8) |
| C-reactive protein (mg/l) | 1.8 (67.2–88.7) |
| History of coronary artery disease | 617/1062 (58) |
| History of cerebrovascular disease | 290/1062 (27) |
| History of peripheral artery disease | 264/1062 (25) |
| History of abdominal aorta aneurysm | 109/1062 (10) |
| Statin use | 721/1046 (69) |
| Antihypertensive medication | 752/1062 (71) |
| Platelet aggregation inhibitors | 792/1051 (75) |
| Oral anticoagulants | 85/1062 (8) |
Values are mean ± standard deviation, n/total (%), or median (interquartile range)
eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MDRD, Modification of Diet in Renal Disease.
| Characteristic . | Population (n = 1062) . |
|---|---|
| Age (years) | 59.2 ± 9.9 |
| Gender (female) | 222/1062 (21) |
| Current smoking | 389/1055 (37) |
| Diabetes | 177/1062 (17) |
| Hypertension | 584/1053 (55) |
| Body mass index (kg/m2) | 26.9 (3.9) |
| Total cholesterol (mmol/l) | 4.9 (1.0) |
| HDL cholesterol (mmol/l) | 1.3 (0.4) |
| LDL cholesterol (mmol/l) | 2.8 (0.9) |
| eGFR (MDRD, ml/min/1.73m2) | 77.4 (17.8) |
| C-reactive protein (mg/l) | 1.8 (67.2–88.7) |
| History of coronary artery disease | 617/1062 (58) |
| History of cerebrovascular disease | 290/1062 (27) |
| History of peripheral artery disease | 264/1062 (25) |
| History of abdominal aorta aneurysm | 109/1062 (10) |
| Statin use | 721/1046 (69) |
| Antihypertensive medication | 752/1062 (71) |
| Platelet aggregation inhibitors | 792/1051 (75) |
| Oral anticoagulants | 85/1062 (8) |
| Characteristic . | Population (n = 1062) . |
|---|---|
| Age (years) | 59.2 ± 9.9 |
| Gender (female) | 222/1062 (21) |
| Current smoking | 389/1055 (37) |
| Diabetes | 177/1062 (17) |
| Hypertension | 584/1053 (55) |
| Body mass index (kg/m2) | 26.9 (3.9) |
| Total cholesterol (mmol/l) | 4.9 (1.0) |
| HDL cholesterol (mmol/l) | 1.3 (0.4) |
| LDL cholesterol (mmol/l) | 2.8 (0.9) |
| eGFR (MDRD, ml/min/1.73m2) | 77.4 (17.8) |
| C-reactive protein (mg/l) | 1.8 (67.2–88.7) |
| History of coronary artery disease | 617/1062 (58) |
| History of cerebrovascular disease | 290/1062 (27) |
| History of peripheral artery disease | 264/1062 (25) |
| History of abdominal aorta aneurysm | 109/1062 (10) |
| Statin use | 721/1046 (69) |
| Antihypertensive medication | 752/1062 (71) |
| Platelet aggregation inhibitors | 792/1051 (75) |
| Oral anticoagulants | 85/1062 (8) |
Values are mean ± standard deviation, n/total (%), or median (interquartile range)
eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MDRD, Modification of Diet in Renal Disease.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
